Fundraising Fox

Syantra

Calgary, CA · 3 known investors

Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.

Founders & leadership

DT
Dr. Tina RinkerCo-founder
TRTina Rinker
Tina RinkerCo-founder
KFKen Fuh
Ken FuhCo-founder
RMRandy Moore
Randy MooreCo-founder
BSBob Shepherd
Bob ShepherdCo-founder

Investors · 3

Competitors · 3

by search overlap

Companies competing with Syantra for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Syantra do?
Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
Who founded Syantra?
Syantra was founded by Dr. Tina Rinker, Tina Rinker, Ken Fuh, Randy Moore, Bob Shepherd.
Who are Syantra's investors?
Syantra's investors include The 51 Ventures, Thin Air Labs, UCeed Funds.
Where is Syantra headquartered?
Syantra is headquartered in Calgary, CA.